Literature DB >> 25644115

Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria.

Katharina Hopp1, Andrea G Cogal1, Eric J Bergstralh2, Barbara M Seide1, Julie B Olson1, Alicia M Meek1, John C Lieske1, Dawn S Milliner3, Peter C Harris4.   

Abstract

Primary hyperoxaluria (PH) is a rare autosomal recessive disease characterized by oxalate accumulation in the kidneys and other organs. Three loci have been identified: AGXT (PH1), GRHPR (PH2), and HOGA1 (PH3). Here, we compared genotype to phenotype in 355 patients in the Rare Kidney Stone Consortium PH registry and calculated prevalence using publicly available whole-exome data. PH1 (68.4% of families) was the most severe PH type, whereas PH3 (11.0% of families) showed the slowest decline in renal function but the earliest symptoms. A group of patients with disease progression similar to that of PH3, but for whom no mutation was detected (11.3% of families), suggested further genetic heterogeneity. We confirmed that the AGXT p.G170R mistargeting allele resulted in a milder PH1 phenotype; however, other potential AGXT mistargeting alleles caused more severe (fully penetrant) disease. We identified the first PH3 patient with ESRD; a homozygote for two linked, novel missense mutations. Population analysis suggested that PH is an order of magnitude more common than determined from clinical cohorts (prevalence, approximately 1:58,000; carrier frequency, approximately 1:70). We estimated PH to be approximately three times less prevalent among African Americans than among European Americans because of a limited number of common European origin alleles. PH3 was predicted to be as prevalent as PH1 and twice as common as PH2, indicating that PH3 (and PH2) cases are underdiagnosed and/or incompletely penetrant. These results highlight a role for molecular analyses in PH diagnostics and prognostics and suggest that wider analysis of the idiopathic stone-forming population may be beneficial.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  genetic renal disease; kidney stones; molecular genetics

Mesh:

Year:  2015        PMID: 25644115      PMCID: PMC4587693          DOI: 10.1681/ASN.2014070698

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  49 in total

Review 1.  Alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting in human hereditary kidney stone disease.

Authors:  Christopher J Danpure; Michael J Lumb; Graeme M Birdsey; Xiaoxuan Zhang
Journal:  Biochim Biophys Acta       Date:  2003-04-11

2.  The variation of urinary oxalate excretion with age.

Authors:  D A Gibbs; R W Watts
Journal:  J Lab Clin Med       Date:  1969-06

3.  AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria.

Authors:  Antonio Amoroso; Doroti Pirulli; Fiorella Florian; Daniela Puzzer; Michele Boniotto; Sergio Crovella; Silvia Zezlina; Andrea Spanò; Gina Mazzola; Silvana Savoldi; Cristina Ferrettini; Silvia Berutti; Michele Petrarulo; Martino Marangella
Journal:  J Am Soc Nephrol       Date:  2001-10       Impact factor: 10.121

Review 4.  Molecular aetiology of primary hyperoxaluria type 1.

Authors:  Christopher J Danpure
Journal:  Nephron Exp Nephrol       Date:  2004

5.  Clinical implications of mutation analysis in primary hyperoxaluria type 1.

Authors:  Christiaan S van Woerden; Jaap W Groothoff; Frits A Wijburg; Carla Annink; Ronald J A Wanders; Hans R Waterham
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

6.  One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience.

Authors:  Maria T Millan; William E Berquist; Sam K So; Minnie M Sarwal; Karen I Wayman; Kenneth L Cox; Guido Filler; Oscar Salvatierra; Carlos O Esquivel
Journal:  Transplantation       Date:  2003-11-27       Impact factor: 4.939

7.  Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase.

Authors:  A Santana; E Salido; A Torres; L J Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-30       Impact factor: 11.205

8.  Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2.

Authors:  David P Cregeen; Emma L Williams; Sally Hulton; Gill Rumsby
Journal:  Hum Mutat       Date:  2003-12       Impact factor: 4.878

Review 9.  Genetic heterogeneity in primary hyperoxaluria type 1: impact on diagnosis.

Authors:  Marion B Coulter-Mackie; Gill Rumsby
Journal:  Mol Genet Metab       Date:  2004 Sep-Oct       Impact factor: 4.797

Review 10.  Primary hyperoxaluria: genotype-phenotype correlation.

Authors:  Doroti Pirulli; Martino Marangella; Antonio Amoroso
Journal:  J Nephrol       Date:  2003 Mar-Apr       Impact factor: 3.902

View more
  72 in total

1.  An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.

Authors:  Abigail Liebow; Xingsheng Li; Timothy Racie; Julia Hettinger; Brian R Bettencourt; Nader Najafian; Patrick Haslett; Kevin Fitzgerald; Ross P Holmes; David Erbe; William Querbes; John Knight
Journal:  J Am Soc Nephrol       Date:  2016-07-18       Impact factor: 10.121

2.  Systematic assessment of urinary hydroxy-oxo-glutarate for diagnosis and follow-up of primary hyperoxaluria type III.

Authors:  Ada Ventzke; Markus Feldkötter; Andrew Wei; Jutta Becker; Bodo B Beck; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2017-07-15       Impact factor: 3.714

3.  Metabolite diagnosis of primary hyperoxaluria type 3.

Authors:  Lawrence Greed; Frank Willis; Lilian Johnstone; Sharon Teo; Ruth Belostotsky; Yaacov Frishberg; James Pitt
Journal:  Pediatr Nephrol       Date:  2018-04-28       Impact factor: 3.714

Review 4.  Recent advances in the identification and management of inherited hyperoxalurias.

Authors:  David J Sas; Peter C Harris; Dawn S Milliner
Journal:  Urolithiasis       Date:  2018-12-10       Impact factor: 3.436

5.  Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria.

Authors:  Ellen R Brooks; Bernd Hoppe; Dawn S Milliner; Eduardo Salido; John Rim; Leah M Krevitt; Julie B Olson; Heather E Price; Gulsah Vural; Craig B Langman
Journal:  Am J Nephrol       Date:  2016-05-03       Impact factor: 3.754

6.  End Points for Clinical Trials in Primary Hyperoxaluria.

Authors:  Dawn S Milliner; Tracy L McGregor; Aliza Thompson; Bastian Dehmel; John Knight; Ralf Rosskamp; Melanie Blank; Sixun Yang; Sonia Fargue; Gill Rumsby; Jaap Groothoff; Meaghan Allain; Melissa West; Kim Hollander; W Todd Lowther; John C Lieske
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-12       Impact factor: 8.237

7.  Identification of 8 novel gene variants in primary hyperoxaluria in 21 Chinese children with urinary stones.

Authors:  Lei He; Guofeng Xu; Xiaoliang Fang; Houwei Lin; Maosheng Xu; Yongguo Yu; Hongquan Geng
Journal:  World J Urol       Date:  2018-11-28       Impact factor: 4.226

8.  HOGA1 Gene Mutations of Primary Hyperoxaluria Type 3 in Tunisian Patients.

Authors:  Saoussen M'dimegh; Cécile Aquaviva-Bourdain; Asma Omezzine; Geneviéve Souche; Ibtihel M'barek; Kamel Abidi; Tahar Gargah; Saoussen Abroug; Ali Bouslama
Journal:  J Clin Lab Anal       Date:  2016-08-26       Impact factor: 2.352

Review 9.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

10.  Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure.

Authors:  Fang Zhao; Eric J Bergstralh; Ramila A Mehta; Lisa E Vaughan; Julie B Olson; Barbara M Seide; Alicia M Meek; Andrea G Cogal; John C Lieske; Dawn S Milliner
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-10       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.